Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: Agrochemical compositions including an agriculturally suitable carrier; one or more encysted or sporulated protozoa (protist); and an agricultural payload including an agrochemical with or without a food source for protozoa such as a agriculturally nonbeneficial bacteria are provided. Also provided is a modified plant seed, and methods for improving plant growth, reducing plant loss to pests, and controlling or eliminating pest infestation of a crop plant, each including use of the described agrochemical compositions.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: A pallet-less brick is provided that allows for materials to be transported without the use of straps or pallets, which makes the transportation and subsequent use of the materials more efficient and more environmentally friendly. The pallet-less brick can have a generally planar body with a series of protrusions and recesses extending in different directions. A protrusion extending in one direction can be received in a recess of an adjacent brick, such that the bricks are stackable without the use of straps or pallets. Similarly, a second protrusion and recess combination fulfill a similar function, and the multiple protrusions and recesses secure stacked pallets in at least two directions.

Abstract: A pallet-less brick is provided that allows for materials to be transported without the use of straps or pallets, which makes the transportation and subsequent use of the materials more efficient and more environmentally friendly. The pallet-less brick can have a generally planar body with a series of protrusions and recesses extending in different directions. A protrusion extending in one direction can be received in a recess of an adjacent brick, such that the bricks are stackable without the use of straps or pallets. Similarly, a second protrusion and recess combination fulfill a similar function, and the multiple protrusions and recesses secure stacked pallets in at least two directions.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.